InsiderClue
Insiders · Profile

Landry Robert E

Director at CYTOKINETICS · EVP Finance CFO at Regeneron Pharmaceuticals. Filing since 5 Aug 2015. CIK 0001585160

CYTK CYTOKINETICS INC Director · 2 trades REGN Regeneron Pharmaceuticals EVP Finance CFO · 45 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CYTK CYTOKINETICS INC
15 Sep 2026
Director
Sold on a plan
1,000
$72.13K
10.9%
CYTK CYTOKINETICS INC
11 Sep 2026
Director
Sold on a plan
1,000
$74.66K
9.8%
REGN Regeneron Pharmaceuticals
23 Aug 2023
EVP Finance CFO
Sold at will
223
$188.21K
0.7%
REGN Regeneron Pharmaceuticals
28 Mar 2023
EVP Finance CFO
Sold on a plan
1,007
$829.23K
3.1%
REGN Regeneron Pharmaceuticals
27 Mar 2023
EVP Finance CFO
Sold on a plan
183
$150.37K
0.6%
REGN Regeneron Pharmaceuticals
6 Feb 2023
EVP Finance CFO
Sold, plan not stated
752
$593.24K
2.3%
REGN Regeneron Pharmaceuticals
3 Feb 2023
EVP Finance CFO
Sold, plan not stated
739
$564.97K
2.3%
REGN Regeneron Pharmaceuticals
2 Dec 2022
EVP Finance CFO
Sold, plan not stated
610
$461.56K
2.1%
REGN Regeneron Pharmaceuticals
1 Nov 2022
EVP Finance CFO
Sold, plan not stated
482
$365.39K
1.6%
REGN Regeneron Pharmaceuticals
17 Oct 2022
EVP Finance CFO
Sold, plan not stated
358
$264.74K
1.2%
REGN Regeneron Pharmaceuticals
11 Apr 2022
EVP Finance CFO
Sold, plan not stated
1,862
$1.37M
6.1%
REGN Regeneron Pharmaceuticals
8 Apr 2022
EVP Finance CFO
Sold, plan not stated
325
$239.78K
1.1%
REGN Regeneron Pharmaceuticals
1 Apr 2022
EVP Finance CFO
Sold, plan not stated
316
$219.88K
1.1%
REGN Regeneron Pharmaceuticals
29 Mar 2022
EVP Finance CFO
Sold, plan not stated
2,683
$1.85M
8.5%
REGN Regeneron Pharmaceuticals
21 Mar 2022
EVP Finance CFO
Sold, plan not stated
300
$207.90K
1.0%
REGN Regeneron Pharmaceuticals
17 Mar 2022
EVP Finance CFO
Sold, plan not stated
83
$56.94K
0.3%
REGN Regeneron Pharmaceuticals
16 Mar 2022
EVP Finance CFO
Sold, plan not stated
300
$203.10K
1.0%
REGN Regeneron Pharmaceuticals
13 Dec 2021
EVP Finance CFO
Sold, plan not stated
116
$76.85K
0.4%
REGN Regeneron Pharmaceuticals
10 Dec 2021
EVP Finance CFO
Sold, plan not stated
781
$520.48K
2.5%
REGN Regeneron Pharmaceuticals
17 Nov 2021
EVP Finance CFO
Sold, plan not stated
681
$439.30K
2.6%
REGN Regeneron Pharmaceuticals
10 Aug 2021
EVP Finance CFO
Sold, plan not stated
537
$328.59K
2.0%
REGN Regeneron Pharmaceuticals
9 Aug 2021
EVP Finance CFO
Sold, plan not stated
364
$224.89K
1.4%
REGN Regeneron Pharmaceuticals
4 Aug 2020
EVP Finance CFO
Sold, plan not stated
696
$455.50K
2.8%
REGN Regeneron Pharmaceuticals
21 Jul 2020
EVP Finance CFO
Sold, plan not stated
391
$253.20K
1.6%
REGN Regeneron Pharmaceuticals
14 Jul 2020
EVP Finance CFO
Sold, plan not stated
579
$370.85K
2.4%
REGN Regeneron Pharmaceuticals
8 Jul 2020
EVP Finance CFO
Sold, plan not stated
1,160
$742.01K
4.6%
REGN Regeneron Pharmaceuticals
29 Jun 2020
EVP Finance CFO
Sold, plan not stated
400
$245.03K
1.6%
REGN Regeneron Pharmaceuticals
23 Jun 2020
EVP Finance CFO
Sold, plan not stated
512
$323.21K
2.1%
REGN Regeneron Pharmaceuticals
11 Jun 2020
EVP Finance CFO
Sold, plan not stated
988
$604.73K
3.9%
REGN Regeneron Pharmaceuticals
9 Jun 2020
EVP Finance CFO
Sold, plan not stated
4,271
$2.60M
14.9%
REGN Regeneron Pharmaceuticals
20 Apr 2020
EVP Finance CFO
Sold, plan not stated
3,250
$1.84M
11.8%
REGN Regeneron Pharmaceuticals
17 Apr 2020
EVP Finance CFO
Sold, plan not stated
991
$552.66K
3.9%
REGN Regeneron Pharmaceuticals
15 Apr 2020
EVP Finance CFO
Sold, plan not stated
853
$442.28K
3.4%
REGN Regeneron Pharmaceuticals
13 Apr 2020
EVP Finance CFO
Sold, plan not stated
828
$422.11K
3.3%
REGN Regeneron Pharmaceuticals
7 Apr 2020
EVP Finance CFO
Sold, plan not stated
696
$346.27K
2.8%
REGN Regeneron Pharmaceuticals
3 Apr 2020
EVP Finance CFO
Sold, plan not stated
683
$337.59K
2.7%
REGN Regeneron Pharmaceuticals
2 Apr 2020
EVP Finance CFO
Sold, plan not stated
1,353
$662.74K
5.1%
REGN Regeneron Pharmaceuticals
1 Apr 2020
EVP Finance CFO
Sold, plan not stated
600
$292.81K
2.4%
REGN Regeneron Pharmaceuticals
26 Feb 2020
EVP Finance CFO
Sold, plan not stated
200
$91.24K
0.8%
REGN Regeneron Pharmaceuticals
25 Feb 2020
EVP Finance CFO
Sold, plan not stated
214
$96.09K
0.8%
REGN Regeneron Pharmaceuticals
13 Feb 2020
EVP Finance CFO
Sold, plan not stated
107
$42.81K
0.4%
REGN Regeneron Pharmaceuticals
6 Sep 2017
SVP Finance & CFO
Sold, plan not stated
474
$235.87K
6.3%
REGN Regeneron Pharmaceuticals
5 Sep 2017
SVP Finance & CFO
Sold, plan not stated
189
$94.70K
2.4%
REGN Regeneron Pharmaceuticals
31 Aug 2017
SVP Finance & CFO
Sold, plan not stated
427
$210.69K
5.7%
REGN Regeneron Pharmaceuticals
23 Aug 2017
SVP Finance & CFO
Sold, plan not stated
468
$222.98K
6.2%
REGN Regeneron Pharmaceuticals
8 Aug 2017
SVP Finance & CFO
Sold, plan not stated
526
$248.37K
6.9%
REGN Regeneron Pharmaceuticals
5 Aug 2015
SVP Finance & CFO
Sold, plan not stated
4,000
$2.37M
36.0%
47 decisions on file.